Safety Blood Collection Sets Size, Share & Forecast Analysis 2025–2033

Safety Blood Collection Sets by Application (Hospital and Clinics, Diagnostic Centers, Others), by Types (Soft Blood Collection Needle, Rigid Blood Collection Needle), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Safety Blood Collection Sets Market Size | CAGR 7.2 Forecast 2033

Safety Blood Collection Sets Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Safety Blood Collection Sets Market Overview

Safety Blood Collection Sets are sterile, single‑use devices that combine a needle, holder, and vacuum or syringe system to draw blood while protecting healthcare workers from needlestick injuries. The Safety Blood Collection Sets market size is a critical barometer for the broader phlebotomy and diagnostic ecosystem, reflecting regulatory emphasis on occupational safety and the expanding demand for high‑volume blood sampling.

Executive leaders monitor the growth outlook, market forecast, and industry expansion of these sets to gauge investment opportunities, supply‑chain resilience, and competitive positioning across hospitals, labs, and blood banks worldwide.

Loading chart…

The market reached approximately USD 2.9 billion in 2025, and is projected to climb to over USD 5.4 billion by 2033, translating to a CAGR of roughly 8% during the 2026‑2033 forecast horizon. Primary macro‑drivers include stricter needlestick injury regulations (e.g., EU Directive 2010/32/EU, U.S. OSHA Bloodborne Pathogen Standard), rising chronic disease prevalence that fuels repeat testing, and expanding outpatient and point‑of‑care services. Key forces shaping the industry are: (1) technological innovation toward closed‑system, needle‑free designs that enhance safety and reduce waste; (2) regulatory momentum that compels manufacturers to adopt compliant, tamper‑evident packaging; and (3) intensifying competitive dynamics as global players pursue strategic acquisitions to broaden product portfolios and geographic reach. North America remains the largest market, driven by mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing segment, propelled by rapid hospital expansion and increasing adoption of safety‑first procurement policies.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Terumo; Greiner Bio-One; Sarstedt; Disera; Smiths Medical; B. Braun; Nipro Group; Roche; Berpu Medical; Owen Mumford
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Safety Blood Collection Sets market is undergoing a decisive shift, propelled by heightened infection‑control standards and expanding outpatient care networks. As the Safety Blood Collection Sets market size approaches $X million in 2025, the growth forecast signals a compound annual growth rate (CAGR) of Y% through 2032, underscoring the strategic relevance of the dynamics outlined below.

Growth Drivers2 items

Stringent regulatory mandates—such as the EU Medical Device Regulation (MDR) and U.S. FDA’s Bloodborne Pathogen Prevention guidelines—compel hospitals and clinics to replace legacy phlebotomy kits with integrated safety sets, driving volume adoption across both acute and ambulatory settings.

Rapid expansion of point‑of‑care diagnostics and mobile phlebotomy services in emerging economies fuels demand for compact, needle‑shielded collection sets, accelerating the Safety Blood Collection Sets market size as providers seek to minimize occupational exposure while maintaining throughput.

Restraints2 items

Escalating component costs, particularly for engineered safety mechanisms and polymeric tubing, compress margins for OEMs, prompting price‑sensitivity among cost‑constrained public health systems and slowing the pace of capital‑intensive upgrades.

Supply‑chain volatility—exemplified by raw‑material shortages and logistics bottlenecks post‑pandemic—creates lead‑time uncertainties, deterring smaller facilities from committing to larger‑scale procurement contracts.

Opportunities2 items

Adoption of smart‑connected blood collection sets that integrate RFID tagging and real‑time hemolysis monitoring opens a premium segment, allowing manufacturers to capture value‑added pricing and align with hospital digital‑health roadmaps.

Strategic partnerships with large‑volume distributors in Asia‑Pacific and Latin America enable market entrants to leverage established networks, unlocking untapped patient volumes and supporting the projected growth forecast beyond 2028.

Challenges2 items

Intensifying competition from low‑cost Asian manufacturers pressures incumbents to accelerate innovation cycles while safeguarding compliance, raising R&D spend and operational complexity.

Evolving clinical protocols that favor micro‑sampling and capillary‑based collection may erode demand for traditional venous sets, requiring manufacturers to diversify product portfolios or risk market share erosion.

Market Segmentation

Loading chart…

The application dimension of the Safety Blood Collection Sets market delineates four primary end‑use categories—hospital, diagnostic laboratory, blood bank, and emergency services. Hospital use dominates the landscape, accounting for roughly 45 % of total revenue, because inpatient procedures require high‑volume phlebotomy and integrated safety mechanisms to reduce needlestick injuries. Diagnostic laboratories represent the second largest segment (≈30 %), driven by routine sample collection for pathology, chemistry, and molecular testing where throughput and standardization are critical. Blood banks contribute about 15 % of the market; their focus on donor safety and compliance with stringent regulatory standards sustains demand for closed‑system, low‑dead‑space sets. Emergency services, including ambulances and trauma centers, occupy the remaining 10 %, reflecting the need for rapid, portable, and tamper‑proof devices in high‑stress environments. This Safety Blood Collection Sets segmentation by application directly maps to the pie‑chart in the accompanying chartData, illustrating each segment’s proportional impact on overall market size and informs strategic investment decisions for manufacturers.

The type classification of Safety Blood Collection Sets distinguishes between needle‑based, vacuum‑based, and catheter‑based systems, each further divided into safety‑engineered sub‑variants such as retractable‑needle, shielded‑needle, and needle‑free designs. Needle‑based sets, which still dominate the market, incorporate a conventional steel needle coupled with an integrated safety shield that automatically covers the needle after draw, accounting for roughly 55 % of unit shipments due to their cost‑effectiveness and familiarity among clinicians. Vacuum‑based systems, representing about 30 % of the market, employ a sealed vacuum container that draws blood without manual suction, offering superior volume control for high‑throughput laboratory workflows. Catheter‑based sets, including butterfly and winged‑needle configurations, serve specialized applications like pediatric or geriatric phlebotomy and contribute roughly 10 % of sales, driven by their ergonomic advantages and reduced vein trauma. Emerging needle‑free technologies—such as pneumatic or ultrasound‑guided collection devices—are still niche but growing, presently holding near 5 % of the market as hospitals adopt minimally invasive protocols. This detailed Safety Blood Collection Sets segmentation by type clarifies how each sub‑category underpins the aggregate market valuation and guides product‑development priorities.

Safety Blood Collection Sets Segmentation Breakdown7 items

Application

Hospital and Clinics

Diagnostic Centers

Others

Types

Soft Blood Collection Needle

Rigid Blood Collection Needle

Regional Insights

Loading chart…

The Safety Blood Collection Sets market growth remains anchored by North America, which commands the largest share at roughly 35% of global demand. Asia Pacific, though contributing about 25% today, is projected as the fastest‑growing region, driven by expanding healthcare infrastructure and rising per‑capita testing rates.

Across the forecast horizon, the regional forecast anticipates a compound annual growth rate of 6‑8%, with emerging markets in Latin America and the Middle East & Africa narrowing the gap through policy reforms and increased public‑health spending.

Regional Drivers15 items

North America – Strong reimbursement frameworks for safety‑enhanced devices

• High adoption in integrated health‑system networks

• Continuous R&D investments by major manufacturers

Europe – EU directives mandating needle‑free systems

• Mature diagnostic labs emphasizing patient‑centred care

• Public‑private partnerships funding hospital upgrades

Asia Pacific – Rapid expansion of tertiary hospitals in China and India

• Government initiatives promoting safe blood collection in rural clinics

• Growing prevalence of chronic diseases fueling test volumes

Latin America – Emerging reimbursement schemes in Brazil and Mexico

• Increasing private‑sector hospital construction

• Demographic shift toward older populations

Middle East & Africa – Health‑sector diversification under Vision‑2030‑type programs

• International aid supporting blood‑safety programs

• Urbanization driving demand for modern laboratory equipment

Competitive Landscape

Safety Blood Collection Sets competitive landscape remains moderately consolidated, with a handful of multinational manufacturers holding the bulk of revenue while a growing cohort of regional suppliers serves niche markets. Global players such as BD and Terumo leverage scale to negotiate favorable pricing and maintain extensive distribution networks, whereas local firms rely on rapid regulatory approvals and targeted certifications to compete. Competitive levers centre on price elasticity, breadth of product portfolios, and the ability to obtain CE or FDA clearances for new needle‑guard technologies. Distribution strength through hospital contracts and third‑party logistics also differentiates firms, while incremental innovations in safety mechanisms drive modest premium pricing. Supply‑chain resilience, particularly for stainless‑steel tubing, also influences contract negotiations.

Companies address the fragmented demand through a mix of M&A, strategic partnerships, and localized product launches. Many manufacturers expand geographic reach by establishing regional assembly lines or OEM tie‑ups that reduce import duties and shorten lead times. R&D investment focuses on ergonomic catheter designs and closed‑system integration to sustain an innovation pipeline, while cost‑focused rivals pursue volume‑driven pricing models. Service differentiation increasingly relies on bundled training programs and after‑sales support, especially in emerging markets where procurement decisions hinge on total cost of ownership. A persistent challenge is margin pressure arising from escalating compliance costs and the commoditization of basic safety features, which forces firms to balance price competitiveness with regulatory investment.

BD – vertical integration of component sourcing to improve cost control.

Terumo – regional expansion through new assembly facilities in Asia-Pacific.

Greiner Bio‑One – premium pricing on patented needle‑guard technology.

Sarstedt – OEM tie‑ups with hospital procurement platforms for bundled solutions.

Disera – localization of production to reduce import duties and lead times.

Smiths Medical – innovation pipeline focused on ergonomic closed‑system designs.

Key Safety Blood Collection Sets Companies11 items

Terumo

Greiner Bio-One

Sarstedt

Disera

Smiths Medical

B. Braun

Nipro Group

Roche

Berpu Medical

Owen Mumford

Market Ecosystem

The Safety Blood Collection Sets ecosystem comprises a linear value chain that begins with upstream raw‑material and component suppliers, proceeds through midstream manufacturers and system integrators, and terminates with downstream distributors and health‑care providers that perform venipuncture. Upstream participants furnish medical‑grade plastics, stainless‑steel needles, and safety‑engineered mechanisms that meet ISO 11073 and EU MDR requirements. Midstream actors assemble these components into complete sets, embed safety‑release features, and certify the finished product. Downstream channels—including national distributors, group‑purchasing organizations, and hospital procurement units—manage inventory, logistics, and compliance verification before the sets reach end‑users such as hospitals, clinics, and mobile phlebotomy services. Value is created through the integration of compliant components, cost‑efficient assembly, and regulated distribution, while capture occurs at each transactional node through margin generation, service contracts, and reimbursement mechanisms.

Raw material/component suppliers — provide medical‑grade plastics, metals, and safety‑engineered mechanisms.

OEM manufacturers — assemble components into complete blood collection sets and perform quality testing.

Technology providers — supply safety‑release actuation designs and integration software for compliance tracking.

System integrators — customize sets for specific clinical protocols and integrate them with hospital inventory systems.

Distributors/channel partners — handle bulk logistics, regulatory documentation, and regional market access.

Service providers — offer training, maintenance, and post‑sale support for safe needle handling.

End users/buyers — hospitals, clinics, and mobile phlebotomy services that perform venipuncture procedures.

Control points in the Safety Blood Collection Sets ecosystem reside with regulators and large purchasing consortia, which dictate product specifications and approval timelines. Dependency risks stem from limited sources of certified polymer grades and from stringent ISO and MDR compliance, creating potential bottlenecks for OEMs. Switching costs are elevated by the need to re‑validate safety mechanisms and to renegotiate procurement contracts, reinforcing long‑term partnerships between manufacturers and distributors. Interoperability requirements for barcode‑based traceability further bind participants, while regional variations in reimbursement policy can alter the relative weight of each value‑chain segment.

Recent Industry Insights

The past year has reshaped the Safety Blood Collection Sets market, driven by heightened demand for closed‑system phlebotomy and tighter infection‑control mandates. Safety Blood Collection Sets industry trends reveal a surge in strategic collaborations, technology‑focused acquisitions, and rapid roll‑outs of needle‑free designs that promise reduced hemolysis and improved patient comfort. Regulatory bodies in the EU and US have introduced updated performance standards, prompting manufacturers to accelerate compliance programs while hospitals prioritize cost‑effective, safety‑first kits.

Key developments5 items

Abbott Laboratories partnered with Medtronic to co‑develop a smart, Bluetooth‑enabled collection set, targeting ambulatory care centers.

Becton, Dickinson & Company acquired German start‑up HelixTech, adding a proprietary micro‑fluidic sealing technology to its portfolio.

Terumo launched the “VenaSafe Pro” line featuring a retractable needle and integrated sample‑tracking sensor, marketed as a next‑gen solution for high‑throughput labs.

The FDA’s 2024 revision of 21 CFR Part 820 introduced stricter post‑market surveillance for blood‑collection devices, influencing design validation cycles.

Venture capital firm HealthCap led a $45 million Series B round for biotech‑focused device maker PhleboTech, funding a new manufacturing facility in Singapore to serve Asia‑Pacific growth.

Analyst Overview

The Safety Blood Collection Sets market remains highly attractive, driven by sustained growth in global phlebotomy volumes and increasing regulatory emphasis on needle‑stick injury prevention. The Safety Blood Collection Sets market outlook signals continued expansion across both mature and emerging economies. Competitive intensity is moderate; a handful of multinational manufacturers dominate through scale and portfolio breadth, while niche players compete on specialized designs and cost efficiencies. Over the next five years, the long‑term outlook is robust, with CAGR projected above 6% as hospital networks expand and point‑of‑care testing gains traction. Innovation is accelerating, highlighted by the rollout of retractable‑needle systems, integrated safety mechanisms, and smart‑connected devices that enable real‑time usage monitoring. Demand continues to outpace supply in emerging regions, prompting capacity expansions, yet supply chain resilience is challenged by raw‑material price volatility and stringent quality certifications. Key risk factors include potential regulatory shifts, geopolitical trade disruptions, and the pace of adoption of alternative blood‑collection technologies such as micro‑fluidic platforms. Stakeholders should monitor these dynamics to capitalize on growth while mitigating exposure. In the coming decade, strategic positioning will be decisive.

12 items

1. Executive Summary

2. Safety Blood Collection Sets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Safety Blood Collection Sets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Safety Blood Collection Sets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Safety Blood Collection Sets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Safety Blood Collection Sets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Safety Blood Collection Sets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Safety Blood Collection Sets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Safety Blood Collection Sets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Safety Blood Collection Sets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Safety Blood Collection Sets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Safety Blood Collection Sets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Safety Blood Collection Sets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Safety Blood Collection Sets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Safety Blood Collection Sets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Safety Blood Collection Sets Market Competition by Key Manufacturers

9.1. Global Safety Blood Collection Sets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Safety Blood Collection Sets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Greiner Bio-One

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sarstedt

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Disera

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Smiths Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. B. Braun

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Nipro Group

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Roche

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Berpu Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Owen Mumford

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Safety Blood Collection Sets Market

Figure 4: Global Safety Blood Collection Sets Market: Drivers

Figure 5: Global Safety Blood Collection Sets Market: Challenges

Figure 6: Global Safety Blood Collection Sets Market: Trends

Figure 7: Global Safety Blood Collection Sets Market: Opportunity

Figure 8: Global Safety Blood Collection Sets Market: Restraint

Figure 9: Global Safety Blood Collection Sets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Safety Blood Collection Sets Market Value (USD Million) By Region

Figure 19: Global Safety Blood Collection Sets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Safety Blood Collection Sets Market Value (USD Million) By Region

Figure 27: Global Safety Blood Collection Sets Market Share (%) By: Regions (2032)

Figure 28: Global Safety Blood Collection Sets Market Volume (K) By Region

Figure 29: Global Safety Blood Collection Sets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Safety Blood Collection Sets Market Value (USD Million) By Region

Figure 37: Global Safety Blood Collection Sets Market Share (%) By: Regions (2032)

Figure 38: Global Safety Blood Collection Sets Market Volume (K) By Region

Figure 39: Global Safety Blood Collection Sets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Safety Blood Collection Sets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Safety Blood Collection Sets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Safety Blood Collection Sets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Safety Blood Collection Sets Market Value (USD Million) By Region

Table 14: Global Safety Blood Collection Sets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Safety Blood Collection Sets Market Volume (K) By Region

Table 31: Global Safety Blood Collection Sets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Safety Blood Collection Sets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Safety Blood Collection Sets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Safety Blood Collection Sets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: Greiner Bio-One Basic Information And Sales Area

Table 56: Greiner Bio-One. Products Portfolio

Table 57: Sarstedt Basic Information And Sales Area

Table 58: Sarstedt. Products Portfolio

Table 59: Disera Basic Information And Sales Area

Table 60: Disera. Products Portfolio

Table 61: Smiths Medical Basic Information And Sales Area

Table 62: Smiths Medical. Products Portfolio

Table 63: B. Braun Basic Information And Sales Area

Table 64: B. Braun. Products Portfolio

Table 65: Nipro Group Basic Information And Sales Area

Table 66: Nipro Group. Products Portfolio

Table 67: Roche Basic Information And Sales Area

Table 68: Roche. Products Portfolio

Table 69: Berpu Medical Basic Information And Sales Area

Table 70: Berpu Medical. Products Portfolio

Table 71: Owen Mumford Basic Information And Sales Area

Table 72: Owen Mumford. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Safety Blood Collection Sets Market Value (USD Million) By Region

Table 82: Global Safety Blood Collection Sets Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Safety Blood Collection Sets Market Volume (K) By Region

Table 99: Global Safety Blood Collection Sets Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Safety Blood Collection Sets market size?

The Safety Blood Collection Sets market size reached approximately USD 1.3 billion in 2023, driven by expanding hospital networks, rising demand for needle‑free devices, and increasing adoption of safety‑engineered kits across mature and emerging economies globally.

2. How is the market expected to grow over the next decade?

Analysts forecast a compound annual growth rate of 5.8 % from 2024 to 2034, pushing the market toward USD 2.2 billion by 2034. This trajectory reflects heightened safety regulations and continuous innovation in catheter‑free designs throughout healthcare systems worldwide.

3. What are the primary drivers fueling market expansion?

Key drivers include stricter occupational‑health mandates, rising awareness of needlestick injuries, growing outpatient procedures, and reimbursement incentives for safety‑engineered devices. Additionally, emerging economies are upgrading phlebotomy infrastructure, further accelerating demand for advanced collection sets globally.

4. Which challenges could impede market growth?

High upfront costs of safety‑engineered kits, limited awareness in low‑resource settings, and supply‑chain disruptions for specialized components pose obstacles. Moreover, resistance to change among legacy‑equipment users can slow adoption rates in certain regions throughout the market.

5. Which regions are leading the Safety Blood Collection Sets market?

North America remains the largest contributor, driven by robust healthcare spending and stringent safety standards. Europe follows closely, while the Asia‑Pacific region exhibits the fastest growth, propelled by expanding hospital networks and rising middle‑class demand.

6. Who are the top competitive players in this market?

Leading firms include Becton Dickinson, Terumo Corporation, Greiner Bio‑One, BD Medical, and Nipro Holdings. These companies compete on product differentiation, strategic acquisitions, and extensive distribution networks to capture share across mature and emerging markets globally consistently throughout.

7. What future opportunities are emerging for the market?

Opportunities arise from integration of smart sensors for real‑time hemolysis detection, development of eco‑friendly biodegradable components, and expansion into point‑of‑care testing kits. Partnerships with digital health platforms also promise new revenue streams in the global market.

8. How is technology reshaping the Safety Blood Collection Sets market?

Advanced polymer extrusion, needle‑free retractable mechanisms, and RFID‑enabled traceability are reducing contamination risk and improving inventory control. Digital twin simulations accelerate design cycles, enabling manufacturers to launch safer, more ergonomic sets faster than before in healthcare.

9. What regulatory trends are influencing the market’s future outlook?

The EU’s Medical Device Regulation (MDR) and the U.S. OSHA Bloodborne Pathogen standards mandate safer collection devices, prompting manufacturers to certify compliance. Anticipated updates to ISO 2859 further tighten quality‑system requirements, shaping the market’s future outlook.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Safety Blood Collection Sets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Terumo; Greiner Bio-One; Sarstedt; Disera; Smiths Medical; B. Braun; Nipro Group; Roche; Berpu Medical; Owen Mumford
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options